Standout Papers

Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Re... 2003 2026 2010 2018 1.0k
  1. Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study (2008)
    David M. Brown, Mark Michels et al. Ophthalmology
  2. Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies (2003)
    Jayakrishna Ambati, Balamurali K. Ambati et al. Survey of Ophthalmology
  3. Randomized, Double-Masked, Sham-Controlled Trial of Ranibizumab for Neovascular Age-related Macular Degeneration: PIER Study Year 1 (2008)
    Carl D. Regillo, David M. Brown et al. American Journal of Ophthalmology

Immediate Impact

38 from Science/Nature 98 standout
Sub-graph 1 of 18

Citing Papers

Interim analyses of a first-in-human phase 1/2 mRNA trial for propionic acidaemia
2024 StandoutNature
Wetting regulates autophagy of phase-separated compartments and the cytosol
2021 StandoutNature
11 intermediate papers

Works of Tsontcho Ianchulev being referenced

Age-Related Macular Degeneration: Etiology, Pathogenesis, and Therapeutic Strategies
2003 Standout
Optic nerve atrophy in propionic acidemia
2003

Author Peers

Author Last Decade Papers Cites
Tsontcho Ianchulev 3734 2893 336 651 50 4.1k
Stacy M. Meuer 4683 3615 469 873 65 5.4k
Michael L. Klein 3056 2102 314 838 61 3.7k
David J. Browning 3509 2913 171 366 88 4.1k
Dennis M. Marcus 4748 3713 191 870 103 5.6k
Philip Hykin 3421 2490 226 493 104 3.9k
Govindasamy Kumaramanickavel 2144 1312 367 1278 105 3.3k
Michele Melia 4954 3831 662 1183 98 6.2k
Laurence Shen Lim 2703 2566 673 485 57 3.7k
Susan Schneider 4157 3055 205 828 31 4.5k
Marco Yu 3041 2827 677 336 100 3.8k

All Works

Loading papers...

Rankless by CCL
2026